Skip to content

Assurant AIZ Equity Securities without Readily Determinable Fair Value, Downward Price Adjustment And Impairment Loss, Cumulative Amount

Other financials

Income statement

See full
Revenue$3.4B+11.3%
Net income$274.1M+87.0%
EPS (diluted)$5.41+91.2%

Balance sheet

See full
Cash & equivalents$1.6B-4.7%
Total debt$73.9M+18.4%
Total equity$5.9B+12.1%
Total assets$35.8B+2.2%

Cash flow

See full
Operating cash flow$240.3M-38.8%
CapEx$47.7M-10.7%
Free cash flow$192.6M-43.2%

Valuation

See full
Market cap$12.88B+1.6%
P/E12.9×-6.0×
P/S-0.1×

Profitability

See full
Net margin7.6%+2.0pp
FCF margin11%-0.7pp

Returns & leverage

See full
Return on equity18%+4.8pp
Debt / equity0.0×

Where this comes from

Reported directly by Assurant in its filing.

Tagged under the XBRL concept aiz:EquitySecuritiesWithoutReadilyDeterminableFairValueDownwardPriceAdjustmentAndImpairmentLossCumulativeAmount.

The official record: Assurant’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Assurant's equity securities without readily determinable fair value, downward price adjustment and impairment loss, cumulative amount.

Connect your AI assistant and see it in context, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Assurant's equity securities without readily determinable fair value, downward price adjustment and impairment loss, cumulative amount?
Assurant (AIZ) reported equity securities without readily determinable fair value, downward price adjustment and impairment loss, cumulative amount of $22.8M in Q1 2026.
How has Assurant's equity securities without readily determinable fair value, downward price adjustment and impairment loss, cumulative amount changed year-over-year?
Assurant's equity securities without readily determinable fair value, downward price adjustment and impairment loss, cumulative amount decreased by 20.0% year-over-year, from $28.5M to $22.8M.
What is the long-term trend for Assurant's equity securities without readily determinable fair value, downward price adjustment and impairment loss, cumulative amount?
Over 2 years (2023 to 2025), Assurant's equity securities without readily determinable fair value, downward price adjustment and impairment loss, cumulative amount has grown at a 12.9% compound annual growth rate (CAGR), from $17.9M to $22.8M.